Last updated: November 29, 2025
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Overall Status: Completed
Phase
N/A
Condition
Fragile X Syndrome
Autism
Neurofibromatosis
Treatment
N/AClinical Study ID
NCT02769949
160103
16-CH-0103
Ages 1-99 All Genders
Study Summary
Eligibility Criteria
Inclusion
INCLUSION CRITERIA:
Subjects of any age with known or suspected genetic disorder
For relatives of subjects with a genetic disorder: Subject is a family member of theproband
Exclusion
EXCLUSION CRITERIA:
-Presence of a medical, psychiatric, or social condition which, in the opinion of the investigator, would place undue burden on the subject, NIH resources, or increase risk of participation
Study Design
Total Participants: 96
Study Start date:
May 03, 2016
Estimated Completion Date:
July 08, 2025
Study Description
Connect with a study center
National Institutes of Health Clinical Center
Bethesda, Maryland 20892
United StatesSite Not Available
National Institutes of Health Clinical Center
Bethesda 4348599, Maryland 4361885 20892
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.